title: Etanercept does not impair healing in rat models of tendon or metaphyseal bone injury.
abstract: OBJECTIVE
  Should blockade of TNF-α be avoided after orthopedic surgery? Healing of injuries in soft tissues and bone starts with a brief inflammatory phase. Modulation of inflammatory signaling might therefore interfere with healing. For example, Cox inhibitors impair healing in animal models of tendon, ligament, and bone injury, as well as in fracture patients. TNF-α is expressed locally at increased levels during early healing of these tissues. We therefore investigated whether blocking of TNF-α with etanercept influences the healing process in established rat models of injury of tendons and metaphyseal bone.
  
  
  METHODS
  Rats were injected with etanercept, 3.5 mg/kg 3 times a week. Healing of transected Achilles tendons and bone healing around screws implanted in the tibial metaphysis were estimated by mechanical testing. Tendons were allowed to heal either with or without mechanical loading. Ectopic bone induction following intramuscular BMP-2 implants has previously been shown to be stimulated by etanercept in rodents. This was now tested as a positive control.
  
  
  RESULTS
  Tendon peak force after 10 days was not significantly influenced by etanercept. Changes exceeding 29% could be excluded with 95% confidence. Likewise, screw pull-out force was not significantly influenced. More than 25% decrease or 18% increase could be excluded with 95% confidence. However, etanercept treatment increased the amount of bone induced by intramuscular BMP-2 implants, as estimated by blind histological scoring.
  
  
  CONCLUSIONS
  Etanercept does not appear to impair tendon or metaphyseal bone healing to any substantial degree.
authors.affiliation: Orthopedics Division, Department of Clinical and Experimental Medicine, Linköping University, SE-581 85 Linköping, Sweden. olof.sandberg@liu.se
authors.forename: Olof
authors.initials: O
authors.lastname: Sandberg
authors.forename: Pernilla
authors.initials: P
authors.lastname: Eliasson
authors.forename: Therese
authors.initials: T
authors.lastname: Andersson
authors.forename: Fredik
authors.initials: F
authors.lastname: Agholme
authors.forename: Per
authors.initials: P
authors.lastname: Aspenberg
mesh_terms: D000009:Abdominal Muscles; D000125:Achilles Tendon / Q000293:injuries*; D000704:Analysis of Variance; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001863:Bone Screws / Q000009:adverse effects; D000068800:Etanercept; D007074:Immunoglobulin G / Q000494:pharmacology*; D009999:Ossification, Heterotopic / Q000188:drug therapy / Q000209:etiology; D019736:Prostheses and Implants / Q000009:adverse effects; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D018124:Receptors, Tumor Necrosis Factor; D013977:Tibia / Q000293:injuries; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept